*Klebsiella pneumoniae* is an important nosocomial pathogen with increasing multi drug resistance capability \[[@B1]\]. At present, there is a limited selection of treatment options for carbapenem-resistant *Enterobacteriaceae* (CRE) infections. There is now a renewed interest in old antimicrobial agents such as polymyxins and fosfomycin.

Data on the activity of fosfomycin against *K. pneumoniae* carbapenemase (KPC)-producing *K. pneumoniae* and New Delhi metallo-β-lactamase (NDM)-1-producing *Enterobacteriaceae* are limited. Use of intravenous fosfomycin monotherapy was proven to effectively control *K. pneumoniae* bacteraemia but can be limited due to its potential resistance development on treatment \[[@B2]\]. Colistin and polymyxin B are known as the most active antimicrobials against CRE \[[@B3]\]. However, in the past few years, there have been sporadic reports of colistin-resistant, CRE cases from various parts of the world including Greece, Israel, South Korea, Singapore and the USA. The exact mechanism(s) of colistin resistance in *Enterobacteriaceae* remain to be unveiled.

Resistance to colistin is mediated mainly via alteration in the lipopolysaccharides of bacterial outer membrane. The alterations include mutations in lipid A modifying genes. The most commonly reported mutations were in the *mgrB* gene and therefore were not transferable through horizontal gene transfer \[[@B4]\]. However, in 2015, the first plasmid-mediated colistin resistance gene (*mcr-1*) was reported \[[@B5]\], which belongs to the phosphoethanolamine transferase enzyme family (*Ept A*). The *mcr-1* was identified in *Escherichia coli* from human patients and animals in China. In 2016, another study reported the mobilizable colistin resistance gene, *mcr*-2 from porcine and bovine *E. coli* isolates in Belgium \[[@B6]\].

Various fosfomycin-modifying enzymes have been identified that act by inactivating the drug. FosA, FosB and FosX are the commonly reported metalloenzymes, while FomA and FomB are kinases. FosA was initially found from a plasmid in *Serratia marcescens* associated with TN2921 transposon \[[@B7]\], while other related FosA type enzymes being reported are FosA3, FosA4, FosA5 and FosC2 \[[@B8]\].

In this study, we performed whole-genome shotgun sequencing of a cluster of colistin-resistant *K. pneumoniae* isolates from North India to identify the molecular mechanism.

Materials & methods {#S0001}
===================

Isolates studied {#S0002}
----------------

A cluster of eight *K. pneumoniae* isolates from clinical samples (blood, bronchoalveolar lavage and urine) resistant to colistin were chosen for complete molecular characterization, using PCR and next-generation sequencing.

Antimicrobial susceptibility testing {#S0003}
------------------------------------

### Disc diffusion {#S0004}

All eight isolates were screened for antimicrobial susceptibility by Kirby--Bauer method using amikacin (30 μg), chloramphenicol (30 μg), tetracycline (30 μg), gentamicin (10 μg), ciprofloxacin (5 μg), cefotaxime (30 μg), cefoxitin (30 μg), ceftazidime (30 μg), cefpodoxime (10 μg), piperacilllin-tazobactam (100/10 μg), cefoperazone-sulbactam (75/30), netilmicin (30 μg), imipenem (10 μg), meropenem (10 μg) and tigecycline (15 μg), according to guidelines suggested by CLSI M100-S25, 2015. Quality control strains used were *E. coli* ATCC 25922 for all antibiotics concurrently in all the batches. Tigecycline results were interpreted according to the US FDA criteria.

### MIC testing {#S0005}

MIC values were determined for meropenem and colistin by broth microdilution method. E-test was performed for fosfomycin MIC using strips with glucose 6-phosphate (bioMérieux, Marcy-l\'Etoile, France). *E. coli* ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as quality control strains for MIC determination of meropenem, fosfomycin and colistin with the expected ranges of 0.008--0.06 μg/ml, 0.5--2 μg/ml and 0.25--2 μg/ml for *E. coli* and 0.12--1 μg/ml, 2--8 μg/ml and 0.5--4 μg/ml for *P. aeruginosa*, respectively. The interpretive criterion provided by CLSI 2015 for susceptible, intermediate and resistant strains were ≤4, 8 and ≥16 μg/ml for meropenem, and ≤64, 128 and ≥256 for fosfomycin, respectively. As per EUCAST 2015, isolates with ≤2 and \>2 μg/ml MIC were recorded as susceptible and resistant for colistin, respectively.

PCR for screening of plasmid-mediated colistin resistance genes {#S0006}
---------------------------------------------------------------

Isolation of total DNA was performed using QIAamp DNA mini kit as per manufacturer\'s instructions (Qiagen, Hilden, Germany). The amplification of colistin resistance genes *mcr-1* and *mcr-2* \[[@B5]\] & \[[@B6]\] was performed using Veriti Thermal cycler (Applied Biosystems, CA, USA).

Next-generation sequencing {#S0007}
--------------------------

Isolates were further analyzed by whole genome sequencing. Genomic DNA was extracted with QIAamp DNA mini kit (Qiagen, Hilden, Germany). Whole genome sequencing was performed using Ion Torrent (PGM) sequencer with 400-bp read chemistry (Life Technologies, CA, USA) according to manufacturer\'s instructions. The data were assembled *de novo* using AssemblerSPAdes version 5.0.0.0 embedded in Torrent suite server version 5.0.3. The sequence annotation was performed in PATRIC, the bacterial bioinformatics database and analysis resource \[[@B9]\], Rapid Annotation using Subsystem Technology (RAST) pipeline \[[@B10]\] and NCBI Prokaryotic Genome Automatic Annotation Pipeline. Downstream analysis was done in the Center for Genomic Epidemiology server ([www.cbs.dtu.dk/services](http://www.cbs.dtu.dk/services)), RAST and PATRIC. The sequence data were used to perform relativeness analysis by eBURST V3, and UPGMA dendogram was generated using MEGA 7. This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank.

Statistical analysis {#S0008}
--------------------

Genome coverage and other parameters were calculated using SPSS 16.0 and Microsoft Excel 2007 (IL, USA).

Results {#S0009}
=======

Antimicrobial susceptibility {#S0010}
----------------------------

The resistance pattern for the colistin-resistant *K. pneumoniae* isolates (n = 8) were as given in [Table 1](#T1){ref-type="table"}. All eight isolates were resistant to cefpodoxime, cefotaxime, ceftazidime, cefoxitin, ciprofloxacin, gentamicin, amikacin, netilmicin and cefoperazone/sulbactam. Isolates except PM5186 were resistant to meropenem and all eight were resistant to colistin by broth microdilution. MICs for colistin ranged from 4--16 μg/ml. Isolate PM716 was resistant to fosfomycin while the remaining were either intermediate or susceptible ([Table 1](#T1){ref-type="table"}).

###### **Phenotypic susceptibility testing and polymerase chain reaction data of colistin-resistant *Klebsiella pneumoniae.***

  **Isolate ID**   **CPD-TAX-CAZ- FOX-CIP-GEN-AMK-NET-CFS**   **PTZ**   **CHL**   **TET**   **TIG**   **IMI**   **MEM**   **Meropenem MIC**   **Colistin MIC**   **Fosfomycin MIC**
  ---------------- ------------------------------------------ --------- --------- --------- --------- --------- --------- ------------------- ------------------ --------------------
  PM1168           R                                          R         R         S         S         R         R         32                  16                 64
                                                                                                                                                                 
  PM565            R                                          R         S         R         R         R         R         32                  8                  64
                                                                                                                                                                 
  PM716            R                                          R         S         S         S         R         R         64                  4                  1024
                                                                                                                                                                 
  PM1134           R                                          R         S         S         S         R         R         128                 4                  128
                                                                                                                                                                 
  PM1842           R                                          R         S         S         S         R         R         16                  8                  64
                                                                                                                                                                 
  PM1995           R                                          R         S         S         S         S         S         8                   8                  128
                                                                                                                                                                 
  PM138            R                                          R         S         R         R         R         R         8                   8                  64

AMK: Amikacin; CAZ: Ceftazidime; CHL: Chloramphenicol; CIP: Ciprofloxacin; CFS: Cefoperazone/sulbactam; CPD: Cefpodoxime; FOX: Cefoxitin; GEN: Gentamycin; IMI: Imipenem; MIC: Minimum inhibitory concentration; MEM: Meropenem; NET: Netilmicin; PTZ: Piperacillin/tazobacam; TAX: Cefotaxime; TET: Tetracycline; TIG: Tigecycline.

Genome analysis {#S0011}
---------------

Raw read assembly of the genome data presented 105--160 contigs (≥ 500 bp). The genome coverage of these isolates were about 32x--51x. The coding sequences (CDSs) of the genomes range from 5859 to 6744, rRNAs from 11 to 14, tRNAs from 64 to 73. The annotation revealed multiple antimicrobial resistance genes ranging from 26 to 38 from ARDB database, and 75--97 from CARD database ([www.patricbrc.org](http://www.patricbrc.org)). Similarly, for virulence genes, the virulence factor database (VFDB) and Victors database revealed the presence of 81--106 and 177--188 genes, respectively ([www.patricbrc.org](http://www.patricbrc.org)) ([Table 2](#T2){ref-type="table"}). Whole genome sequencing of all eight isolates were deposited in Genbank/DDBJ under the accession numbers as follows: PM565 - MNPB00000000; PM1842 - MNPC00000000; PM1995 - MNPD00000000; PM138 - MNPG00000000; PM716 - MNPH00000000; PM1134 - MNPF00000000; PM5186 - MNPE00000000 and PM1168 - MNPA00000000.

###### **Whole genome characteristics of colistin-resistant *Klebsiella pneumoniae.***

  **Parameters/isolates**       **PM1168**   **PM565**   **PM1842**   **PM1995**   **PM716**   **PM1134**   **PM5186**   **PM138**
  ----------------------------- ------------ ----------- ------------ ------------ ----------- ------------ ------------ -----------
  Genome Size (bp)              5,554,499    5,650,616   5,577,703    5,583,954    5,727,677   5,735,750    5,440,451    5,774,696
                                                                                                                         
  Genome coverage               32x          40x         43x          51x          43x         40x          41x          38x
                                                                                                                         
  Number of contigs (≥500 bp)   119          127         110          105          108         132          111          160
                                                                                                                         
  CDS                           5907         5945        5859         6056         6415        6615         6194         6744
                                                                                                                         
  rRNA                          11           14          14           13           13          12           12           13
                                                                                                                         
  tRNA                          68           69          70           70           69          64           73           66
                                                                                                                         
  ARDB                          35           27          26           29           38          36           36           34
                                                                                                                         
  CARD                          84           77          75           82           96          97           91           89
                                                                                                                         
  VFDB                          82           81          82           89           69          67           85           106
                                                                                                                         
  Victors                       180          177         177          184          187         185          187          188

CDS: Coding seqences; VFDB: Virulence factor database.

The sequence type of the isolates were found to be ST11 for PM565, PM1842, PM1995, PM138, ST14 for PM716, PM1134, and ST231 for PM5186 and PM1168 as analysed by MLST 1.8 tool (<https://cge.cbs.dtu.dk//services/MLST/>). ResFinder 2.1 ([www.cbs.dtu.dk/services](http://www.cbs.dtu.dk/services)) returned multiple antimicrobial resistance genes for most of the antibiotic classes ([Table 3](#T3){ref-type="table"}). Interestingly fosfomycin, fluoroquinolone, aminoglycoside and β-lactam resistant determinants were found in all eight isolates. The *fosA* genes observed in these isolates were different from the existing six variants and reported for the first time in this study ([Figure 1](#F0001){ref-type="fig"}). However, plasmid mediated colistin resistance determinants *mcr-1* and *mcr-2* were not found in any of the isolates.

###### **Antimicrobial resistance genes and plasmid profiles of colistin-resistant *Klebsiella pneumoniae.***

  **Isolate ID**   **Aminoglycosides**                                      **Beta lactams**                                                                **Fluoroquinolones**   **Fosfomycin**   **Macrolide**      **Phenicol**   **Rifampicin**   **Sulphonamide**   **Trimethoprim**   **Plasmids**
  ---------------- -------------------------------------------------------- ------------------------------------------------------------------------------- ---------------------- ---------------- ------------------ -------------- ---------------- ------------------ ------------------ -------------------------------------------------------
  PM565            *aacA4, strA, strB, rmtf, aac(6′)Ib-cr*                  *blaOXA-232, blaTEM-1B, blaCTX-M-15, blaSHV- 11*                                *qnrB1*                *fosA*           --                 *--*           *ARR- 2*         *sul2*             --                 ColKP3, IncR, IncFII(K), IncHI1B, IncFIB(pQil)
                                                                                                                                                                                                                                                                                             
  PM1842           *aacA4, strA, strB, rmtf, aac(6′)Ib-cr*                  *blaOXA-232,blaTEM- 1B,blaCTX-M-15, blaSHV- 11*                                 *qnrB1*                *fosA*           *--*               *--*           *ARR- 2*         *sul2*             --                 ColKP3, IncR, IncFII(K), IncHI1B, IncFIB(pQil)
                                                                                                                                                                                                                                                                                             
  PM1995           *aacA4, strA, strB, rmtf, aac(6′)Ib-cr*                  *blaTEM- 1B, blaCTXM-15, blaLEN12*                                              *qnrB1*                *fosA*           *--*               *--*           *ARR- 2*         *sul2*             --                 IncR, IncFII(K), IncHI1B, IncFIB(pQil)
                                                                                                                                                                                                                                                                                             
  PM138            *aacA4, strA, strB, rmtf, aac(6′)Ib-cr*                  *blaOXA-232, blaTEM-1B, blaCTX-M-15, blaSHV-11*                                 *qnrB1*                *fosA*           *--*               *--*           *ARR-2*          *sul2*             --                 ColKP3, IncR, IncFII(K), IncHI1B, IncFIB(pQil)
                                                                                                                                                                                                                                                                                             
  PM716            *aadA2, aadA1, aacA4, armA, aph(3′)-Via, aac(6′)Ib-cr*   *blaOXA-232, blaTEM-1B, blaOXA-9, blaOXA-1, blaSHV-28, blaNDM-1, blaCTX-M-15*   *qnrS1, oqxA, oqxB*    *fosA*           *msr(E), mph(E)*   *catB3*        *--*             *sul1*             *dfrA12, dfrA1*    IncHI1B, IncFIB(Mar), IncFIB(pQil), IncFII(K), ColKP3
                                                                                                                                                                                                                                                                                             
  PM1134           *aadA2, aadA1, aacA4, armA, aph(3′)-Via, aac(6′)Ib-cr*   *blaOXA-181, blaTEM-1B, blaOXA-9, blaOXA-1, blaSHV-28, blaNDM-1, blaCTX-M-15*   *qnrS1, oqxA, oqxB*    *fosA*           *msr(E), mph(E)*   *catB3*        *--*             *sul1*             *dfrA12, dfrA1*    IncHI1B, IncFIB(Mar), IncFIB(pQil), IncFII(K), ColKP3
                                                                                                                                                                                                                                                                                             
  PM5186           *aacA4, rmtf, aadA2, aac(6′)Ib-cr*                       *blaTEM-1B, blaSHV-1, blaCTX-M-15*                                              *oqxA, oqxB*           *fosA*           *mph(A), erm(B)*   *catA1*        *ARR-2*          *sul1*             *dfrA12*           IncFIB(pQil), IncFII(K), IncFIA
                                                                                                                                                                                                                                                                                             
  PM1168           *aadA2, rmtf, aacA4, aac(6′)Ib-cr*                       *blaOXA- 232, blaTEM- 1B, blaSHV-12, blaCTXM-15*                                *qnrS1, oqxA, oqxB*    *fosA*           *mph(A), erm(B)*   *catA1*        *ARR- 2*         *sul1*             *dfrA12*           IncFIB(pQil), IncFII(K), IncFIA

![**Clustal alignment depicting amino acid differences among the FosA proteins observed in the study isolates and known variants of FosA.**](fsoa-04-319-g1){#F0001}

Plasmid analysis {#S0012}
----------------

Plasmids screening was performed using PlasmidFinder 1.3 (<https://cge.cbs.dtu.dk//services/PlasmidFinder/>). On analysis of plasmids using PlasmidFinder 1.3 ([www.cbs.dtu.dk/services](http://www.cbs.dtu.dk/services)), IncFII(K) and IncFIB(pQil) were found in all isolates in addition to few other plasmids ([Table 3](#T3){ref-type="table"}).

Mutational analysis {#S0013}
-------------------

Multiple mutations were observed in the genes responsible for lipid A modification and Ara-4 N pathway in *K. pneumoniae* isolates ([Table 4](#T4){ref-type="table"}). Interestingly, novel (R157S in *arnT* & Q319R in *eptA*) and rare mutations (V39L, R152H, S260L, A279G in *eptA*) were observed in the isolates studied. R157S in *arnT* was observed in all the isolates, whereas Q319R in *eptA* was observed in PM565, PM1995, PM138 and PM1842. It is important to note that there were deletions of three amino acids LLG at 521, 522 and 523 ([Table 4](#T4){ref-type="table"}). PM1168 and PM5186 had mutations in *mgrB* gene, V1A and L24H, respectively.

###### **Cumulative results of various mutations (amino acid) found upon whole genome sequencing analysis of colistin-resistant *Klebsiella pneumoniae.***

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Genes**   **Lipid A modifications**   **Lipid A-Ara4N pathway (polymyxin resistance)**                                                                                                                                  
  ----------- --------------------------- -------------------------------------------------- ------- ------- ------- ------ -------- ----------------------- ------ -------- -------- ------ --------------- ------- ------ ------
  PM565       ST11                        None                                               F170I   D150G   R114A   None   D150H\   C27F\                   None   I260L\   None     S30T   Q156H\          W52L\   None   None
                                                                                                                            R256G\   V39L\                          N442K                    R157S\          V53I\          
                                                                                                                            L344P    A279G\                                                  R372K           I94L\          
                                                                                                                                     Q319R                                                                   I300V          

                                                                                                                                                                                                                            

  PM716       ST14                        None                                               F170I   D150G   R114A   None   T157P\   V42L\                   None   I260L\   G47D\    S30T   Q156H\          S164P   None   None
                                                                                                                            A246T\   S260L                          N442K    A112D\          R158S\                         
                                                                                                                            L344P                                            I126V           R372K                          

                                                                                                                                                                                                                            

  PM1134      ST14                        None                                               F170I   D150G   R114A   None   T157P\   V39L\                   None   I260L\   G47D\    S19T   Q156H\          S164P   None   None
                                                                                                                            A246T\   S257L                          N442K    A112D\          R157S\                         
                                                                                                                            L344P                                            I126V           R372K                          

                                                                                                                                                                                                                            

  PM1168      ST231                       V1A                                                None    D150G   R114A   None   L344P    V39L,\                  None   I260L\   A112D\   S30T   Q156H\          NONE    None   None
                                                                                                                                     R152H\                         N442K    D285E           R157S\                         
                                                                                                                                     D477N                                                   I474N                          

                                                                                                                                                                                                                            

  PM1995      ST11                        None                                               F190I   D150G   R114A   None   D150H\   C27F\                   None   I260L\   None     S30T   Q156H\          I94L\   None   None
                                                                                                                            R256G\   V39L\                          N442K                    R157S\          I300V          
                                                                                                                            L344P    Q319R                                                   R372K                          

                                                                                                                                                                                                                            

  PM138       ST11                        None                                               F189I   D150G   R114A   None   D150H\   C27F\                   None   I260L\   None     S19T   Q156H\          I94L\   None   None
                                                                                                                            R256G\   V39L\                          N442K                    R157S\          I300V          
                                                                                                                            L344P    Q319R                                                   R372K                          

                                                                                                                                                                                                                            

  PM5186      ST231                       L24H                                               None    D150G   R114A   None   L344P    V39L\                   None   I260L\   A112D\   S30T   Q156H\          NONE    NONE   None
                                                                                                                                     R152H\                         N442K    D285E           R157S\                         
                                                                                                                                     D477N                                                   I474N                          

                                                                                                                                                                                                                            

  PM1842      ST11                        None                                               F170I   D150G   R114A   None   D150H\   C27F\                   None   I260L\   None     S30T   Q156H, R157S\   I94L\   None   None
                                                                                                                            R256G\   V39L\                          N442K                    R372K           I300V          
                                                                                                                            L344P    Q319R\                                                                                 
                                                                                                                                     A279G\                                                                                 
                                                                                                                                     521,522, 523: DEL LLG                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion {#S0014}
==========

Currently, there are increasing reports of CRE which results in less choice of antimicrobials for therapy. Fosfomycin is gaining interest for the treatment of carbapenem-resistant *K. pneumoniae* \[[@B2]\]. In this scenario, resistance to fosfomycin is an alarming threat to those treating infections by *Enterobacteriaceae*, especially nosocomial pathogens.

The eight selected colistin-resistant *K. pneumoniae* isolates were observed to be of three different clonal types (ST11, ST14 and ST231) as observed by eBURST analysis and UPGMA dendogram ([Figures 2](#F0002){ref-type="fig"} & [3](#F0003){ref-type="fig"}). These were the commonly reported sequence types previously reported from India \[[@B11]\]. Also, among the seven meropenem-resistant isolates, *bla* ~OXA~ producers; *bla* ~OXA-232~ (n = 5) and *bla* ~OXA181~ (n = 1) were commonly seen followed by *bla* ~NDM-1~ (n = 2).

![**Comparative eBURST of colistin-resistant *Klebsiella pneumoniae* isolates based on MLST.**](fsoa-04-319-g2){#F0002}

![**Dendrogram of colistin-resistant *Klebsiella pneumoniae* isolates to show the clonal similarity using dendroUPGMA.**](fsoa-04-319-g3){#F0003}

Polymyxins are known to serve as drug of choice for carbapenem-resistant *K. pneumoniae* either alone or in combination. Polymyxin acts like cationic detergents and disrupts the cytoplasmic membrane by attacking phosphate groups of membrane phospholipid; this ultimately leads to leakage of cytoplasmic contents and death of cell \[[@B12]\]. In this regard, lipid A modification genes were largely known to be involved in chromosomal-mediated colistin resistance. Among the seven genes which are known to be involved in the lipid A modifications (*paqP*, *pmrA*, *pmrB*, *phoP*, *phoQ*, *eptA* and *eptB*), only four genes (*pmrA*, *pmrB*, *phoP* and *phoQ*) were extensively discussed in the literature. In *K. pneumoniae*, mutations including G53C, E35A in *pmrA* \[[@B13]\]; S85R, T140P, T157P, S205P \[[@B13]\], T157P \[[@B14]\], T157P and S208N with deletion of three nucleotide at 14 and 209 in *pmrB* \[[@B15]\]; L26Q in *phoP* \[[@B13]\]; S174N and L384Q in *phoQ* \[[@B15]\] were previously reported.

In this study, mutations were observed in ten genes (*paqP*, *pmrB*, *phoP*, *phoQ* and *eptA* of lipid A modifications and *arnA_DH/FT*, *arnB*, *arnC*, *arnT* and *pmrJ* of lipid A-Ara4N pathway) which includes novel (R157S in *arnT* & Q319R in *eptA*) and rare mutations (V39L, R152H, S260L and A279G in *eptA*) which might be conferring for colistin resistance. Recently, in one of our studies, we have observed novel mutations in *eptA* gene of lipid A modification pathway and *arnT* gene of lipid A-Ara4N pathway among cluster of isolates from South India \[[@B4]\]. Also, two study isolates (PM1168 and PM5186) exhibited mutations in *mgrB* gene, the most commonly reported genetic determinant for colistin resistance. L24H observed in PM5186 was previously reported by Cannatelli *et al*. \[[@B16]\], whereas V1A (GTG - GCC) was not previously reported. However, no major change was observed in colistin MIC levels for the isolates with and without mutation in *mgrB*. The role of observed mutations in colistin resistance development should be further analyzed with confirmatory tests.

It is also worth noting that there were deletions of LLG aminoacids in *eptA* gene in one isolate (PM1842). The *arnT* gene belonging to L-Ara4N moiety and *eptA* were known to be responsible for attachment of modified arabinose to lipid A 4′-phosphate group. This reduces bacterial susceptibility towards polymyxin and cationic antimicrobial peptides \[[@B17]\].

Interestingly, plasmid-mediated colistin resistance genes *mcr-1* and *mcr-2* were not seen in these isolates. In spite of their absence, the isolates were resistant to colistin (with MICs 8 and 16 μg/ml) indicating the clinical importance of chromosomal mutations in the lipid A modification pathway.

In addition, intravenous fosfomycin had been proposed as a treatment option for systemic infections by resistant *K. pneumoniae* \[[@B18]\]. However, resistance may develop to fosfomycin during treatment. Resistance to fosfomycin involves various mechanisms, majorly chromosomal-mediated and plasmid-mediated. Transferable plasmids with fosfomycin-resistant determinants result in accelerated dissemination of fosfomycin resistance. Also, *fosA* and *fosB* were reported to be responsible for plasmid-mediated resistance, whereas *fosX* was cited to be responsible for chromosomal-mediated resistance \[[@B18]\]. The *fosA* gene encodes a glutathione S-transferase and *fosB* encodes an L-cysteine thiol transferase, while *fosX* encodes an epoxide hydrolase \[[@B19]\]. Among these *fosA* seems to be widely reported in *K. pneumoniae* isolates \[[@B20]\]. To date, six variants of *fosA* have been reported worldwide which includes *fosA* (NC_011617.1), *fosA2* (ACC85616.1), *fosA3* (NC_019073.1), *fosA4* (WP_034169466.1), *fosA5* (NC_022374.1) and *fosA6* (AMQ12811.1). However, to the best of our knowledge, reports are lacking at variant level identification of *fosA* from India. In this study we observed clusters of *K. pneumoniae* isolates with novel *fosA* variants. The variant numbers (PM1168 -- *fosA7*; PM716 -- *fosA8*; PM138, PM1995, PM1842 -- *fosA9*; PM5186 -- *fosA10*; PM565 -- *fosA11* and PM1134 -- *fosA12*) were assigned based on the phylogenetic variation of *fosA* genes ([Figure 4](#F0004){ref-type="fig"}). The isolate with *a fosA8* gene had a high MIC of 1024 μg/ml for fosfomycin. However, all other variants of *fosA* genes reported in this study were noted to be either susceptible or moderately susceptible to fosfomycin. In addition, eight more *K. pneumoniae* isolates were screened for *fosA* genes, where all eight were positive for the gene but phenotypically susceptible to fosfomycin. Further studies are required to understand the mechanisms behind fosfomycin resistance and the non-functional variants.

![**Dendrogram of novel *fosA* variants in colistin-resistant - *Klebsiella pneumoniae* isolates.**](fsoa-04-319-g4){#F0004}

Conclusion {#S0015}
==========

Overall the study reports novel and rare mutations in the *arnT* gene of the Ara-4 N pathway and the *eptA* gene of lipid A modifications. The complex combination of such mutations leads to high MIC levels for colistin. The result of the study provide an argument for continuous surveillance of the molecular mechanism behind the colistin resistance.

Future perspective {#S0016}
==================

Most recently, colistin resistance is rapidly increasing among *K. pneumoniae*. The major mechanism reported for colistin resistance is mutations in lipid A modification genes, in which several novel mutations are being reported. Functional validation of such mutations might reveal the level of resistance with each mutation. Plasmid-mediated colistin resistance is seen predominantly in animals, while chromosomal-mediated resistance is higher in humans. It is important to better understand resistance mechanisms -- either chromosomal- or plasmid-mediated -- and the trend of plasmid-mediated resistance will help us to delineate transmission dynamics of animal to human spread. This information will facilitate the appropriate containment of colistin-resistant pathogen infections.

###### Summary points

-   To the best of our knowledge, variants of *fos A* from India have not yet been characterized. The study reports novel variants of *fos A* genes at amino acid level from colistin-resistant *Klebsiella pneumoniae*. The variant numbers (PM1168 -- *fosA7*; PM716 -- *fosA8*; PM138, PM1995, PM1842 -- *fosA9*; PM5186 -- *fosA10* and PM565 -- *fosA11*) were assigned based on the phylogenetic variation of *fosA* genes.

-   The study also reports novel mutations in *arnT* gene of Ara-4 N pathway and rare mutations in *eptA* gene of lipid A modification pathway involved in contributing to colistin resistance.

-   The plasmid-mediated colistin resistance genes *mcr-1* and *mcr-2* were absent in all eight *K. pneumoniae* isolates.

-   *The bla* ~OXA-232~ was seen in most of the isolates, conferring resistance to carbapenem.

-   IncFII(K) and IncFIB(pQil) plasmids were seen predominantly in all isolates.

-   The common sequence types observed from this study were ST-11 followed by ST-14 and ST-231.
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